Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
129,929,313
-
Total 13F shares
-
43,222,434
-
Share change
-
-799,671
-
Total reported value
-
$972,744,067
-
Price per share
-
$22.51
-
Number of holders
-
74
-
Value change
-
-$14,050,462
-
Number of buys
-
46
-
Number of sells
-
26
Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q2 2021
As of 30 Jun 2021 Vaxcyte, Inc. - COMMON STOCK (PCVX) had 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 43,222,434 shares of stock of the company.
Largest 10 holders included FMR LLC, TPG Group Holdings (SBS) Advisors, Inc., Abingworth LLP, JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, BlackRock Inc., FRAZIER MANAGEMENT LLC, Medicxi Ventures Management (Jersey) Ltd, and STATE STREET CORP.
This table shows 74 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.